TOYO Pharmaceutical Co., Ltd.
FDA inspection history in Osaka, Japan, 2023
- 1
- Form 483
Every document, by year
- Form 483
2023: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2023One Form 483, at Osaka, Japan.
Cited most
Across all TOYO Pharmaceutical Co. observations on file
- 21 CFR 211.100(b)Written procedures; deviations1
- 21 CFR 211.25(a)Personnel qualifications1
The complete TOYO Pharmaceutical Co. file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Osaka, Japan
One Form 483 · 2023 · 2 observations
Latest: Form 483, Jun 16, 2023 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2023-06-16 | 483 Form 483 | Osaka, Japan | 2 | $99 |
Investigators on these documents
FEI number 3016419927 · most recent document Jun 16, 2023
About TOYO Pharmaceutical Co., Ltd.
How many FDA Form 483s has TOYO Pharmaceutical Co., Ltd. received?
FDA Intel has 1 Form 483 on file for TOYO Pharmaceutical Co., Ltd.; the most recent is dated Jun 16, 2023.
When was TOYO Pharmaceutical Co., Ltd. last inspected by FDA?
The most recent FDA inspection document on file for TOYO Pharmaceutical Co., Ltd. is a Form 483 dated Jun 16, 2023, for the site in Osaka, Japan.
What did FDA cite at TOYO Pharmaceutical Co., Ltd.?
The regulations cited most in the observations on file for TOYO Pharmaceutical Co., Ltd. are 21 CFR 211.100(b) (Written procedures; deviations), 1 time; 21 CFR 211.25(a) (Personnel qualifications), 1 time.